EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis

BACKGROUND: Despite growing interest, there is no guidance or consensus on how to conduct clinical trials and observational studies in populations at risk of rheumatoid arthritis (RA). METHODS: An European League Against Rheumatism (EULAR) task force formulated four research questions to be addresse...

Descripción completa

Detalles Bibliográficos
Autores principales: Mankia, Kulveer, Siddle, Heidi J, Kerschbaumer, Andreas, Alpizar Rodriguez, Deshire, Catrina, Anca Irinel, Cañete, Juan D, Cope, Andrew P, Daien, Claire Immediato, Deane, Kevin D, El Gabalawy, Hani, Finckh, Axel, Holers, V Michael, Koloumas, Marios, Ometto, Francesca, Raza, Karim, Zabalan, Condruta, van der Helm-van Mil, Annette, van Schaardenburg, Dirkjan, Aletaha, Daniel, Emery, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Recommendation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458095/
https://www.ncbi.nlm.nih.gov/pubmed/34362746
http://dx.doi.org/10.1136/annrheumdis-2021-220884

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458095/
https://www.ncbi.nlm.nih.gov/pubmed/34362746
http://dx.doi.org/10.1136/annrheumdis-2021-220884

Ejemplares similares